Celera Announces Deal For Berkeley HeartLab
Celera of Rockville announced this morning that it plans to buy to Berkeley HeartLab, Inc., a privately held cardiovascular healthcare company that provides tests and disease management services.
The company will pay about $195 million in cash, minus certain transaction costs.
Berkeley HeartLab says it provides physicians and patients with a "personalized cardiovascular risk management program encompassing nutrition, exercise, medication compliance, and stress reduction in concert with advanced lipid and other cardiovascular and metabolic testing services. In calendar 2006, BHL received referrals from over 4,100 physicians, processed samples from over 150,000 patients, and performed over 1.6 million tests."
Please email us to report offensive comments.
The comments to this entry are closed.